Cost-effectiveness of secondary screening modalities for hypertension. - Wikidata - wikimedia - TriplyDB

Cost-effectiveness of secondary screening modalities for hypertension.

Cost-effectiveness of secondary screening modalities for hypertension.

http://www.wikidata.org/entity/Q37651806

about

Diagnosing hypertension: Evidence supporting the 2015 recommendations of the Canadian Hypertension Education Program Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.Ambulatory blood pressure monitoring in clinical practice: a review.Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.Use of ambulatory blood pressure monitoring to guide hypertensive therapy.Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure.Diagnostiquer l’hypertension artérielle: Données probantes à l’appui des recommandations 2015 du Programme éducatif canadien sur l’hypertension.Ambulatory blood pressure monitoring in daily practice.

P2860

Q26777273-35725EC6-7350-4EAD-B7D5-77AB7D481979 Q34675203-8551082C-30ED-4BF1-B474-CF5CD81A1E0F Q36928328-D21CEBE1-4FB2-48DB-9E6A-E1730C78A1BB Q38118631-7072AAB6-140E-462A-99E3-E161184A61A4 Q38120450-8F5EE381-2BFF-4E33-A21F-03B5F40BC3CD Q39013933-C8FD4904-0290-43F5-9BF8-2CD95B8E6167 Q45859659-CFB207F1-DEB4-442F-95EE-B7A3D4270CCD Q49646814-BB2BB52C-D334-453E-B1A6-E1068542A24D

P2860

Cost-effectiveness of secondary screening modalities for hypertension.

http://www.wikidata.org/entity/Q37651806

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cost-effectiveness of secondary screening modalities for hypertension.

@en

Cost-effectiveness of secondary screening modalities for hypertension.

@nl

type

label

Cost-effectiveness of secondary screening modalities for hypertension.

@en

Cost-effectiveness of secondary screening modalities for hypertension.

@nl

prefLabel

Cost-effectiveness of secondary screening modalities for hypertension.

@en

Cost-effectiveness of secondary screening modalities for hypertension.

@nl

P1433

Q37651806-3E37841C-506C-4FE6-9AF9-6D96BE9C5588

P1476

Q37651806-4C5994B8-6496-4A94-8057-8D54CAA8E7C9

P2093

Q37651806-18A0A7A8-69EE-4889-9B93-A85093838B5F

Q37651806-53A3A638-DF40-4A17-B2C4-F6503CFBD170

Q37651806-6E9D924E-EEC4-44E9-9966-A84379CEBCB6

Q37651806-DC069322-6A45-44CB-9BEC-0FFEC2FD73EB

P2860

Q37651806-00B58101-F115-4614-B14D-03046786BEE7

Q37651806-03FA466A-D4AB-4D0E-966E-9CBCD2D2E5F0

Q37651806-0C385DE7-7CDB-4E65-92A8-B3A10A457CC4

Q37651806-167D07E1-E255-40BE-B689-9BD856480D27

Q37651806-1EC0DED5-0059-4F5A-BED0-15C22FC7E683

Q37651806-310B87B6-E1A6-4D76-AC92-387829E48DE4

Q37651806-32B3133D-9F04-43A8-AF3D-DFDE916AD6D8

Q37651806-36921AA7-1B1B-4A33-AE78-960D57E6AFF4

Q37651806-3974A33F-0B3F-4D8C-9D1A-8C5315A8AD27

Q37651806-3B9546F7-F544-476E-94F9-14621566DC8E

P304

Q37651806-5AA7E707-49EB-4783-9F38-E299E8F0A7B4

P31

Q37651806-DADEA896-2A92-42E7-B2A0-F4689FB8C8C4

P356

Q37651806-B8809747-ECA1-4848-B31C-C064AA3DC7B1

P433

Q37651806-B6600972-6DB8-404B-922E-5CE4C2A237D1

P478

Q37651806-C5B08056-E171-42D8-9D24-0651A4DD7E1E

P50

Q37651806-03F15561-036F-489A-A923-2688EEEE6BCF

Q37651806-EAC3CD57-4198-45F9-8DDE-A5E9429DA7B9

P577

Q37651806-3E82AA70-48EB-44B3-9875-8352E13236F7

P698

Q37651806-65E8706D-0F3C-4FE4-B6C0-C85EE1002B10

P921

Q37651806-181DD0B9-1D5F-4A41-9FCC-0397CAEB0EF8

P932

Q37651806-200EF0BF-8ED0-46CF-8949-FC288A82F170

P356

MBP.0B013E32835D0FD3

P1433

Blood Pressure Monitoring

P1476

Cost-effectiveness of secondary screening modalities for hypertension.

@en

P2093

Alisa M Koval

http://www.w3.org/2001/XMLSchema#string

Miyabi Nakamura

http://www.w3.org/2001/XMLSchema#string

Patricia W Stone

http://www.w3.org/2001/XMLSchema#string

Y Claire Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care

Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study.

The case for home monitoring in hypertension

Prognostic value of ambulatory blood pressure : current evidence and clinical implications.

Home blood pressure monitoring.

How common is white coat hypertension?

Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study.

Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MBP.0B013E32835D0FD3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Newman

Joseph Schwartz

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23263535

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3960995

http://www.w3.org/2001/XMLSchema#string